Deerfield Management Company »

Genmab A/s -sp shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Genmab A/s -sp (GMAB) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Genmab A/s -sp

Tip: Access up to 7 years of quarterly data

All positions including Genmab A/s -sp held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genmab A/s -sp by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $66M 2.5M 26.83

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Celcuity (CELC)
Centene Corporation (CNC)
Larimar Therapeutics (LRMR)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Genmab A/s -sp

Orbis Allan Gray
Alliancebernstein
Paradigm Biocapital Advisors
Arrowstreet Capital, Limited Partnership
BlackRock
Deep Track Capital
Renaissance Technologies
Harding Loevner
Deerfield Management Company
First Trust Advisors
Two Sigma Investments
Morgan Stanley
Federated Investors
Franklin Resources
Pictet Asset Management Holding SA

View all funds holding Genmab A/s -sp